EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Living Donor Liver Transplantation in Patients with or Without Acute-on-Chronic Liver Failure: A Single Center Experience

Bandar Aljudaibi, Lama Alshehri, Bedour Almudaiheem iD, Samra Mirza, Ahmad Mirza, Aiko Danish, Mir Hakam Qazi, Mohammed Shoaib, Yousef Hamed, Massimo Malago, Dimitri Raptis, Saleh Alabbad und 7 weitere

Journal of Clinical Medicine · 15.04.2026 · 15 (8) · 3007

DOI: 10.3390/jcm15083007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.04.2026. Verfasst von Bandar Aljudaibi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Organ Transplant Centre of Excellence, King Faisal Specialists and Research Centre, Riyadh 11211, Saudi Arabia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Acute-on-chronic liver failure (ACLF) is a severe syndrome in chronic liver disease (CLD) patients, characterized by multi-organ failure and high mortality. Living donor liver transplantation (LDLT) is vital in donor-scarce areas. This study compares baseline characteristics, perioperative complications, and long-term survival between ACLF and non-ACLF patients, emphasizing etiology, ACLF grading, and graft factors.

Methods

Data from a prospective registry of 591 adult LDLT recipients (2019–2023) were analyzed. ACLF was defined by EASL-CLIF (multi-organ failure, grades 1–3) and APASL (jaundice/coagulopathy with complications) criteria, evaluated at initial assessment and within 24 h pre-LDLT.

Results

ACLF patients (n = 101, 17.1%) showed higher MELD-Na (27 vs. 20, p < 0.001), bilirubin (6.84 vs. 1.75 mg/dL, p < 0.001), creatinine (108 vs. 70.5 μmol/L, p < 0.001), metabolic/genetic etiologies (9.9% vs. 2.8%, p = 0.001), and chronic kidney disease (23.7% vs. 8.1%, p < 0.001), and lower HCC rates (11.8% vs. 29.6%, p < 0.001). GRWR was marginally lower in ACLF patients (0.59 vs. 0.66, p = 0.10). The ACLF group had elevated infection (27.7% vs. 10.4%, p < 0.001), bleeding (14.9% vs. 6.3%, p = 0.004), and biliary complications (15.8% vs. 7.8%, p = 0.010), with longer ICU (5 vs. 3 days, p < 0.001) and hospital stays (33.66 vs. 20.7 days, p = 0.036). Five-year overall survival was reduced in ACLF patients (log-rank p = 0.001), worsening with grade (EASL-CLIF grade 3: 55% vs. 81% for no ACLF, p = 0.002). Graft survival was also lower (75% vs. 85%, p = 0.02). Multivariable analysis identified chronic kidney disease as an independent mortality predictor (HR 2.09, 95% CI 1.11–3.95, p = 0.023).

Conclusions

LDLT for ACLF involves higher perioperative risks and poorer long-term survival than non-ACLF patients, with outcomes deteriorating by ACLF grade. Chronic kidney disease independently predicts mortality. Timely LDLT is essential in donor-limited regions.

Schlagwörter

Stichwörter der Autor:innen

ACLF gradingMELD-Na scoreacute-on-chronic liver failurechronic kidney diseasechronic liver diseasegraft survivalliving donor liver transplantationlong-term survivalperioperative complications

Autor:innen und Institutionen

  • Organ Transplant Centre of Excellence, King Faisal Specialists and Research Centre, Riyadh 11211, Saudi Arabia.
  • College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.

ORCID-Profile: Bedour Almudaiheem, Ehab Abufarhaneh, Khalid Bzeizi

Zitieren

APA

Aljudaibi, B., Alshehri, L., Almudaiheem, B., Mirza, S., Mirza, A., Danish, A., Qazi, M. H., Shoaib, M., Hamed, Y., Malago, M., Raptis, D., Alabbad, S., Saner, F., Alghamdi, S., Alfhaid, A., Abufarhaneh, E., Alqahtani, S., Broering, D., & Bzeizi, K. (2026). Living Donor Liver Transplantation in Patients with or Without Acute-on-Chronic Liver Failure: A Single Center Experience. Journal of Clinical Medicine, 15(8), 3007. https://doi.org/10.3390/jcm15083007

Vancouver

Aljudaibi B, Alshehri L, Almudaiheem B, Mirza S, Mirza A, Danish A, et al. Living Donor Liver Transplantation in Patients with or Without Acute-on-Chronic Liver Failure: A Single Center Experience. Journal of Clinical Medicine. 2026;15(8):3007. doi:10.3390/jcm15083007

BibTeX
@article{Aljudaibi2026,
  author = {Aljudaibi, Bandar and Alshehri, Lama and Almudaiheem, Bedour and Mirza, Samra and Mirza, Ahmad and Danish, Aiko and Qazi, Mir Hakam and Shoaib, Mohammed and Hamed, Yousef and Malago, Massimo and Raptis, Dimitri and Alabbad, Saleh and Saner, Fuat and Alghamdi, Saad and Alfhaid, Abdullah and Abufarhaneh, Ehab and Alqahtani, Saleh and Broering, Dieter and Bzeizi, Khalid},
  title = {Living Donor Liver Transplantation in Patients with or Without Acute-on-Chronic Liver Failure: A Single Center Experience},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {3007},
  doi = {10.3390/jcm15083007}
}
Kostenlos starten →